Accent Capital Management’s Generation Bio GBIO Stock Holding History

Accent Capital Management’s Portfolio GBIO Stock Details GBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-61	Closed	-$53.3K	–	313
2026 Q1	$53.3K	Buy	61 +35	+135%	+$195	0.03%	101
2025 Q4	$17K	Sell	26 -12	-32%	-$68	0.01%	150
2025 Q3	$23.4K	Buy	38 +34	+850%	+$176	0.01%	138
2025 Q2	$20.1K	Buy	+4	New	+$15	0.01%	167

Accent Capital Management's GBIO Position: Q2 2026 in Review

Accent Capital Management sold out of Generation Bio (GBIO) in Q2 2026, closing a stake of 61 shares — an estimated $53.3K sold.

Accent Capital Management first reported a position in GBIO in Q2 2025 and held it in 4 quarters. The position peaked at $53.3K in Q1 2026. 0 funds tracked by Wall St. Rank hold GBIO as of Q2 2026.

Accent Capital Management reported no remaining Generation Bio position as of Q2 2026 after selling out during the quarter.
Accent Capital Management sold 61 Generation Bio shares in Q2 2026, an estimated $53.3K.
Accent Capital Management first reported a position in Generation Bio in Q2 2025 and held it in 4 quarters.
Accent Capital Management's Generation Bio position peaked at $53.3K in Q1 2026.
0 funds tracked by Wall St. Rank held Generation Bio as of Q2 2026.

Based on Accent Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.